Xiuling Tang – Trademark Portfolio

Entity Type: 01

Xiuling Tang owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as OVDOES, ESTRUSOFA, and PIPITETEK. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 25 (Clothing) and Class 9 (Computers & Electronics). Headquartered in Hunan Province.

Group 4, Penxi Village, Liangshan Town

Hunan Province 422700 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ESTRUSOFA
ESTRUSOFA
Registered 2020
OVDOES
OVDOES
Registered 2020
PIPITETEK
PIPITETEK
Registered 2020

Trademark Classifications

Xiuling Tang's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Xiuling Tang have?

Xiuling Tang has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Xiuling Tang file in?

Xiuling Tang files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Xiuling Tang's most well-known trademarks?

Xiuling Tang's registered trademark portfolio includes well-known marks such as OVDOES, ESTRUSOFA, and PIPITETEK. These are among 3 currently registered trademarks in the portfolio.

What is Xiuling Tang's trademark registration success rate?

Xiuling Tang has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.